Showing results (1-10 of 406) with videos related to
Sort By:
Pageof 41
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
LenalidomideKatja Weisel, Lothar KanzAnnals of Hematology|July 1, 2014
Lenalidomide in relapsed and refractory multiple myeloma disease: feasibility and benefits of long-term treatmentManola Zago, Katharina Oehrlein, Corinna Rendl, et al.Haematologica|December 30, 2006
Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphomaJörg T Hartmann, Ines Meisinger, Stefan M Kröber, et al.Transfusion|September 25, 2014
Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusionChristof Weinstock, Robert Möhle, Christiane Dorn, et al.Clinical Transplantation|May 5, 2017
Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantationCorina Schneidawind, Silke Duerr-Stoerzer, Christoph Faul, et al.Seminars in Hematology|July 17, 2007
Hematopoietic growth factors for hematopoietic stem cell mobilization and expansionRobert Möhle, Lothar KanzOncotargets and Therapy|October 28, 2016
Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to dateKatja WeiselBlood Reviews|October 27, 2004
Dendritic cells in vaccination therapies of human malignant diseaseVolker L Reichardt, Peter Brossart, Lothar KanzCurrent Opinion in Infectious Diseases|April 20, 2002
Molecular methods in the diagnosis of infections in the immunocompromised hostHolger Hebart, Juergen Loeffler, Lothar Kanz, et al.Anti-Cancer Drugs|August 31, 2006
Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamideHans-Georg Kopp, Lothar Kanz, Joerg T HartmannPageof 41